Delivery Order SPE2DB22D3301-SPE2DB25FX8LA

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,149.02 firm fixed-price delivery order is for the supply of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $1,801.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VALTOCO 5 MG nasal sprays. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VALTOCO 10 MG NASAL SPRAYS. The $1,439.65 firm fixed-price delivery order contract has a completion date of November 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VALTOCO 10 MG NASAL SPRAYS. The firm-fixed-price delivery order, valued at $1,979.40, has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VALTOCO 10 MG nasal sprays. The contract, valued at $1,253.65, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on June 24, 2024. It is a Firm Fixed Price delivery order with a completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,729.28 firm fixed-price delivery order is for the supply of VALTOCO 15 MG Nasal Sprays, with a period of performance through December 5, 2024. The contract was not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award is a delivery order valued at $6,812.46 issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VALTOCO 15 MG NASAL SPRAYS to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract has a completion date of February 21, 2025 and is a firm fixed price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,849.58 firm fixed-price delivery order is for the supply of VALTOCO 15 MG nasal sprays, with a completion date of October 17, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of VALTOCO 15 MG NASAL SPRAYS to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $5,523.34 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 19, 2024. The contract has an ultimate completion date of December 20, 2024 and does not have a set-aside designation, indicating open competition....
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8LA
    Delivery Order

This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of VALTOCO 5 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $2,120.54 firm fixed-price delivery order has a completion date of January 15, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 4/16/25, 5:46 PM